These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Impact of silencing eEF2K expression on the malignant properties of chordoma. Aydemir E; Tüysüz EC; Bayrak ÖF; Tecimel D; Hızlı-Deniz AA; Şahin F Mol Biol Rep; 2023 Apr; 50(4):3011-3022. PubMed ID: 36652154 [TBL] [Abstract][Full Text] [Related]
47. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102 [TBL] [Abstract][Full Text] [Related]
48. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia. McCamphill PK; Ferguson L; Sossin WS J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161 [TBL] [Abstract][Full Text] [Related]
49. PQBP1 promotes translational elongation and regulates hippocampal mGluR-LTD by suppressing eEF2 phosphorylation. Shen Y; Zhang ZC; Cheng S; Liu A; Zuo J; Xia S; Liu X; Liu W; Jia Z; Xie W; Han J Mol Cell; 2021 Apr; 81(7):1425-1438.e10. PubMed ID: 33662272 [TBL] [Abstract][Full Text] [Related]
50. Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress. Xie J; Van Damme P; Fang D; Proud CG J Biol Chem; 2019 May; 294(18):7169-7176. PubMed ID: 30890561 [TBL] [Abstract][Full Text] [Related]
51. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Leprivier G; Remke M; Rotblat B; Dubuc A; Mateo AR; Kool M; Agnihotri S; El-Naggar A; Yu B; Somasekharan SP; Faubert B; Bridon G; Tognon CE; Mathers J; Thomas R; Li A; Barokas A; Kwok B; Bowden M; Smith S; Wu X; Korshunov A; Hielscher T; Northcott PA; Galpin JD; Ahern CA; Wang Y; McCabe MG; Collins VP; Jones RG; Pollak M; Delattre O; Gleave ME; Jan E; Pfister SM; Proud CG; Derry WB; Taylor MD; Sorensen PH Cell; 2013 May; 153(5):1064-79. PubMed ID: 23706743 [TBL] [Abstract][Full Text] [Related]
52. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2. Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489 [TBL] [Abstract][Full Text] [Related]
53. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. Browne GJ; Finn SG; Proud CG J Biol Chem; 2004 Mar; 279(13):12220-31. PubMed ID: 14709557 [TBL] [Abstract][Full Text] [Related]
54. A functional eEF2K-eEF2 pathway in the NAc is critical for the expression of cocaine-induced psychomotor sensitisation and conditioned place preference. Beiser T; Lisniansky E; Weitz M; Bingor A; Grad E; Rosenblum K; Thornton C; Yaka R Transl Psychiatry; 2022 Nov; 12(1):460. PubMed ID: 36319619 [TBL] [Abstract][Full Text] [Related]
55. Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy. Wang H; Jin W; Li Z; Guo C; Zhang L; Fu L Drug Discov Today; 2024 Oct; 29(10):104155. PubMed ID: 39214495 [TBL] [Abstract][Full Text] [Related]
56. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. Kenney JW; Moore CE; Wang X; Proud CG Adv Biol Regul; 2014 May; 55():15-27. PubMed ID: 24853390 [TBL] [Abstract][Full Text] [Related]